Atossa Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATOS research report →
About the company
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medicines. Their primary focus lies in addressing unmet medical needs in women's oncology, especially breast cancer, along with other conditions, within the United States.
- CEO
- Steven C. Quay
- IPO
- 2012
- Employees
- 15
- HQ
- Seattle, WA, US
Price Chart
- Market Cap
- $18.26M
- P/E
- -0.49
- P/S
- 0.00
- P/B
- 0.60
- EV/EBITDA
- 0.36
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -84.91%
- ROIC
- -129.89%
- Revenue
- $0 · 0.00%
- Net Income
- $-34,770,000 · -36.33%
- EPS
- $-4.04 · -34.67%
- Op Income
- $-37,141,000
- FCF YoY
- -41.50%
- 52W High
- $19.35
- 52W Low
- $1.70
- 50D MA
- $4.23
- 200D MA
- $8.11
- Beta
- 1.25
- Avg Volume
- 139.01K
Get TickerSpark's AI analysis on ATOS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 12, 26 | Steinhart Richard I | other | 10,000 |
| May 12, 26 | Chen Shu-Chih | other | 10,000 |
| May 12, 26 | Remmel H. Lawrence | other | 10,000 |
| May 12, 26 | Finn Jonathan | other | 10,000 |
| May 12, 26 | Galli Stephen J | other | 10,000 |
| May 12, 26 | Cigler Tessa | other | 10,000 |
| Mar 27, 26 | QUAY STEVEN C | other | 65,000 |
| Mar 26, 26 | Daniel Mark James | other | 63,000 |
| Jan 20, 26 | QUAY STEVEN C | other | 331,674 |
| Jan 20, 26 | QUAY STEVEN C | other | 950,000 |
Our ATOS coverage
Recent articles, reports, and earnings notes.
No research on ATOS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ATOS report →Similar companies
Peers in the same neighborhood.